Recursion Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Recursion Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Recursion Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Recursion Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $19M | 3.9M | 4.88 |
| 2025-06-30 | $23M | 4.6M | 5.06 |
| 2025-03-31 | $30M | 5.6M | 5.29 |
| 2024-12-31 | $20M | 3.0M | 6.76 |
| 2024-09-30 | $5.3M | 800k | 6.59 |
| 2024-06-30 | $12M | 1.6M | 7.50 |
| 2024-03-31 | $6.7M | 672k | 9.97 |
| 2023-12-31 | $6.8M | 692k | 9.86 |
| 2023-09-30 | $2.6M | 343k | 7.65 |
| 2023-06-30 | $1.3M | 169k | 7.47 |
| 2023-03-31 | $1.1M | 169k | 6.67 |
| 2022-12-31 | $2.8M | 362k | 7.71 |
| 2022-09-30 | $193k | 19k | 10.45 |
| 2022-06-30 | $41k | 5.0k | 8.12 |
| 2022-03-31 | $49k | 6.9k | 7.13 |
| 2021-12-31 | $4.4M | 259k | 17.14 |
| 2021-09-30 | $1.6M | 71k | 23.06 |
| 2021-06-30 | $26k | 700 | 37.14 |